Investor Presentaiton slide image

Investor Presentaiton

LOVVOLUS • JEUVEAU EXTRA-STRENGTH PHASE II DURATION STUDY STUDY DESIGN Multi-center, double blind, randomized, active controlled 5 sites • N=150 Three arms, randomization 1:1:1 • 40U Prabotulinum 20U Prabotulinum • 20U Onabotulinum Duration 769 • 1 year, or until return to baseline Study population • Stable healthy adults, min 18 years of age Moderate (GLS=2) to Severe (GLS=3) glabellar lines at max frown Year
View entire presentation